Search

Your search keyword '"Korshunov, VA"' showing total 44 results

Search Constraints

Start Over You searched for: Author "Korshunov, VA" Remove constraint Author: "Korshunov, VA" Search Limiters Full Text Remove constraint Search Limiters: Full Text
44 results on '"Korshunov, VA"'

Search Results

1. Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021

2. Diabetes mortality and trends before 25 years of age: an analysis of the Global Burden of Disease Study 2019

3. Population-level risks of alcohol consumption by amount, geography, age, sex, and year: a systematic analysis for the Global Burden of Disease Study 2020

4. Measuring routine childhood vaccination coverage in 204 countries and territories, 1980-2019: a systematic analysis for the Global Burden of Disease Study 2020, Release 1

5. Global injury morbidity and mortality from 1990 to 2017: results from the Global Burden of Disease Study 2017

6. Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019

7. Estimating global injuries morbidity and mortality: methods and data used in the Global Burden of Disease 2017 study.

8. Population-level risks of alcohol consumption by amount, geography, age, sex, and year: a systematic analysis for the Global Burden of Disease Study 2020

10. Reduction of Hippocampal High-Frequency Activity in Wag/Rij Rats with a Genetic Predisposition to Absence Epilepsy.

11. Role of PDE10A in vascular smooth muscle cell hyperplasia and pathological vascular remodelling.

12. Healthcare Workers' Acceptance of COVID-19 Vaccination in Russia.

13. Natriuretic Peptide Receptor 2 Locus Contributes to Carotid Remodeling.

14. The Protective Role of Natriuretic Peptide Receptor 2 against High Salt Injury in the Renal Papilla.

15. Strain-selective efficacy of sacubitril/valsartan on carotid fibrosis in response to injury in two inbred mouse strains.

16. Aged marrow macrophages expand platelet-biased hematopoietic stem cells via Interleukin1B.

17. Innate Immune Cells Are Regulated by Axl in Hypertensive Kidney.

18. Model-based vascular elastography improves the detection of flow-induced carotid artery remodeling in mice.

19. Role of Axl in T-Lymphocyte Survival in Salt-Dependent Hypertension.

20. Axl modulates immune activation of smooth muscle cells in vein graft remodeling.

21. Autonomic dysfunction determines stress-induced cardiovascular and immune complications in mice.

22. Thalidomide ameliorates portal hypertension via nitric oxide synthase independent reduced systolic blood pressure.

23. Intima modifier locus 2 controls endothelial cell activation and vascular permeability.

24. Role of Axl in early kidney inflammation and progression of salt-dependent hypertension.

25. Platelet factor 4 mediates vascular smooth muscle cell injury responses.

26. G-protein-coupled receptor kinase interacting protein-1 mediates intima formation by regulating vascular smooth muscle proliferation, apoptosis, and migration.

27. Identification of a genetic locus on chromosome 11 that regulates leukocyte infiltration in mouse carotid artery.

28. Ribosomal protein L17, RpL17, is an inhibitor of vascular smooth muscle growth and carotid intima formation.

29. Genetic locus on mouse chromosome 7 controls elevated heart rate.

30. Immune modulation of vascular resident cells by Axl orchestrates carotid intima-media thickening.

31. Gas6-Axl pathway: the role of redox-dependent association of Axl with nonmuscle myosin IIB.

32. Fibronectin is an important regulator of flow-induced vascular remodeling.

33. Bcr kinase activation by angiotensin II inhibits peroxisome-proliferator-activated receptor gamma transcriptional activity in vascular smooth muscle cells.

34. Genetic modifier loci linked to intima formation induced by low flow in the mouse carotid.

35. Axl mediates vascular remodeling induced by deoxycorticosterone acetate-salt hypertension.

36. Vascular remodeling: hemodynamic and biochemical mechanisms underlying Glagov's phenomenon.

37. Angiotensin II type 2 receptor expression after vascular injury: differing effects of angiotensin-converting enzyme inhibition and angiotensin receptor blockade.

38. Axl, a receptor tyrosine kinase, mediates flow-induced vascular remodeling.

39. Role of nuclear Ca2+/calmodulin-stimulated phosphodiesterase 1A in vascular smooth muscle cell growth and survival.

40. Interleukin-18 and macrophage migration inhibitory factor are associated with increased carotid intima-media thickening.

41. Genetic determinants of vascular remodelling.

42. Strain-dependent vascular remodeling: the "Glagov phenomenon" is genetically determined.

43. Hydrogen peroxide activates the Gas6-Axl pathway in vascular smooth muscle cells.

44. Flow-induced vascular remodeling in the mouse: a model for carotid intima-media thickening.

Catalog

Books, media, physical & digital resources